516 related articles for article (PubMed ID: 32379755)
1. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
[TBL] [Abstract][Full Text] [Related]
2. Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice.
Chiang JI; Furler J; Mair F; Jani BD; Nicholl BI; Thuraisingam S; Manski-Nankervis JA
BMJ Open; 2020 Nov; 10(11):e039625. PubMed ID: 33243798
[TBL] [Abstract][Full Text] [Related]
3. Multimorbidity, glycaemic variability and time in target range in people with type 2 diabetes: A baseline analysis of the GP-OSMOTIC trial.
Chiang JI; Manski-Nankervis JA; Thuraisingam S; Jenkins A; O'Neal D; Mair FS; Jani BD; Nicholl BI; Furler J
Diabetes Res Clin Pract; 2020 Nov; 169():108451. PubMed ID: 32949650
[TBL] [Abstract][Full Text] [Related]
4. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
[TBL] [Abstract][Full Text] [Related]
5. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study.
Heikkala E; Mikkola I; Jokelainen J; Timonen M; Hagnäs M
BMC Health Serv Res; 2021 Sep; 21(1):964. PubMed ID: 34521389
[TBL] [Abstract][Full Text] [Related]
6. Multimorbidity in a selected cohort compared to a representative sample: Does selection bias influence outcomes?
Hanlon P; Bhautesh J; Mair F; McAllister D
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696232
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Physical Activity Intensity on the Dynamic Progression of Cardiometabolic Multimorbidity: Prospective Cohort Study Using UK Biobank Data.
Liu BP; Zhu JH; Wan LP; Zhao ZY; Wang X; Jia CX
JMIR Public Health Surveill; 2023 Sep; 9():e46991. PubMed ID: 37747776
[TBL] [Abstract][Full Text] [Related]
8. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Risk Factors Associated With Venous Thromboembolism.
Gregson J; Kaptoge S; Bolton T; Pennells L; Willeit P; Burgess S; Bell S; Sweeting M; Rimm EB; Kabrhel C; Zöller B; Assmann G; Gudnason V; Folsom AR; Arndt V; Fletcher A; Norman PE; Nordestgaard BG; Kitamura A; Mahmoodi BK; Whincup PH; Knuiman M; Salomaa V; Meisinger C; Koenig W; Kavousi M; Völzke H; Cooper JA; Ninomiya T; Casiglia E; Rodriguez B; Ben-Shlomo Y; Després JP; Simons L; Barrett-Connor E; Björkelund C; Notdurfter M; Kromhout D; Price J; Sutherland SE; Sundström J; Kauhanen J; Gallacher J; Beulens JWJ; Dankner R; Cooper C; Giampaoli S; Deen JF; Gómez de la Cámara A; Kuller LH; Rosengren A; Svensson PJ; Nagel D; Crespo CJ; Brenner H; Albertorio-Diaz JR; Atkins R; Brunner EJ; Shipley M; Njølstad I; Lawlor DA; van der Schouw YT; Selmer RM; Trevisan M; Verschuren WMM; Greenland P; Wassertheil-Smoller S; Lowe GDO; Wood AM; Butterworth AS; Thompson SG; Danesh J; Di Angelantonio E; Meade T;
JAMA Cardiol; 2019 Feb; 4(2):163-173. PubMed ID: 30649175
[TBL] [Abstract][Full Text] [Related]
10. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study.
Muilwijk M; Ho F; Waddell H; Sillars A; Welsh P; Iliodromiti S; Brown R; Ferguson L; Stronks K; van Valkengoed I; Pell JP; Gray SR; Gill JMR; Sattar N; Celis-Morales C
BMJ Open Diabetes Res Care; 2019; 7(1):e000765. PubMed ID: 31908795
[TBL] [Abstract][Full Text] [Related]
11. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
[TBL] [Abstract][Full Text] [Related]
12. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.
Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK
BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.
Fontvieille E; Viallon V; Recalde M; Cordova R; Jansana A; Peruchet-Noray L; Lennon H; Heath AK; Aune D; Christakoudi S; Katzke V; Kaaks R; Inan-Eroglu E; Schulze MB; Mellemkjær L; Tjønneland A; Overvad K; Farràs M; Petrova D; Amiano P; Chirlaque MD; Moreno-Iribas C; Tin Tin S; Masala G; Sieri S; Ricceri F; Panico S; May AM; Monninkhof EM; Weiderpass E; Gunter MJ; Ferrari P; Freisling H
BMC Med; 2023 Nov; 21(1):418. PubMed ID: 37993940
[TBL] [Abstract][Full Text] [Related]
14. Influence of social deprivation on morbidity and all-cause mortality of cardiometabolic multi-morbidity: a cohort analysis of the UK Biobank cohort.
Jiang Z; Zhang S; Zeng P; Wang T
BMC Public Health; 2023 Nov; 23(1):2177. PubMed ID: 37932741
[TBL] [Abstract][Full Text] [Related]
15. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data.
Zghebi SS; Steinke DT; Rutter MK; Ashcroft DM
BMJ Open; 2020 Jul; 10(7):e033866. PubMed ID: 32611677
[TBL] [Abstract][Full Text] [Related]
16. Multimorbidity and frailty in middle-aged adults with type 2 diabetes mellitus.
Hanlon P; Jani B; Mair F; McAllister D
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36857144
[TBL] [Abstract][Full Text] [Related]
17. Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review.
Chiang JI; Jani BD; Mair FS; Nicholl BI; Furler J; O'Neal D; Jenkins A; Condron P; Manski-Nankervis JA
PLoS One; 2018; 13(12):e0209585. PubMed ID: 30586451
[TBL] [Abstract][Full Text] [Related]
18. Role of Pulmonary Function in Predicting New-Onset Cardiometabolic Diseases and Cardiometabolic Multimorbidity.
Li G; Lu Y; Qiao Y; Hu D; Ke C
Chest; 2022 Aug; 162(2):421-432. PubMed ID: 35032479
[TBL] [Abstract][Full Text] [Related]
19. Exploring multimorbidity profiles in middle-aged inpatients: a network-based comparative study of China and the United Kingdom.
Bao Y; Lu P; Wang M; Zhang X; Song A; Gu X; Ma T; Su S; Wang L; Shang X; Zhu Z; Zhai Y; He M; Li Z; Liu H; Fairley CK; Yang J; Zhang L
BMC Med; 2023 Dec; 21(1):495. PubMed ID: 38093264
[TBL] [Abstract][Full Text] [Related]
20. Role of depression in the development of cardiometabolic multimorbidity: Findings from the UK Biobank study.
Qiao Y; Ding Y; Li G; Lu Y; Li S; Ke C
J Affect Disord; 2022 Dec; 319():260-266. PubMed ID: 36162655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
